BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 8.10.2002

Agency Information Collection Activities; Submission for OMB Review; Comment Request; Current Good Manufacturing Practices and Related Regulations for Blood and Blood Components; and “Lookback” Requirements

The Food and Drug Administration (FDA) is announcing that the proposed collection of information listed below has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

Source: Federal Register — Food and Drug AdministrationOpen original release →